These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 17673327)
1. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM Lung Cancer; 2007 Nov; 58(2):267-74. PubMed ID: 17673327 [TBL] [Abstract][Full Text] [Related]
2. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma. Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748 [TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer. Cooper WA; Kohonen-Corish MR; McCaughan B; Kennedy C; Sutherland RL; Lee CS Histopathology; 2009 Jul; 55(1):28-36. PubMed ID: 19614764 [TBL] [Abstract][Full Text] [Related]
4. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM Am J Clin Pathol; 2007 Dec; 128(6):1002-9. PubMed ID: 18024326 [TBL] [Abstract][Full Text] [Related]
5. Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer. Hansen LV; Skov BG; Ploug M; Pappot H Lung Cancer; 2007 Nov; 58(2):260-6. PubMed ID: 17706320 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205 [TBL] [Abstract][Full Text] [Related]
7. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer. Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438 [TBL] [Abstract][Full Text] [Related]
8. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival. Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237 [TBL] [Abstract][Full Text] [Related]
9. HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer. Lin A; Zhang X; Ruan YY; Wang Q; Zhou WJ; Yan WH Lung Cancer; 2011 Dec; 74(3):504-9. PubMed ID: 21561677 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of immunohistochemical Rac1 expression in survival in early operable non-small cell lung cancer. Yuan K; Qian C; Zheng R Med Sci Monit; 2009 Nov; 15(11):BR313-9. PubMed ID: 19865048 [TBL] [Abstract][Full Text] [Related]
12. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Al-Shibli KI; Donnem T; Al-Saad S; Persson M; Bremnes RM; Busund LT Clin Cancer Res; 2008 Aug; 14(16):5220-7. PubMed ID: 18698040 [TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Schütt P; Schütt B; Switala M; Bauer S; Stamatis G; Opalka B; Eberhardt W; Schuler M; Horn PA; Rebmann V Hum Immunol; 2010 May; 71(5):489-95. PubMed ID: 20156510 [TBL] [Abstract][Full Text] [Related]
14. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer]. Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer. Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769 [TBL] [Abstract][Full Text] [Related]
16. [Tissue array analysis of the aberrant expression of HLA class I molecules in human non small cell lung cancer]. Suzuki H; Higuchi M; Hasegawa T; Yonechi A; Ohsugi J; Yamada F; Hoshino M; Shio Y; Fujiu K; Gotoh M Gan To Kagaku Ryoho; 2006 Nov; 33(12):1713-6. PubMed ID: 17212084 [TBL] [Abstract][Full Text] [Related]
17. Expression of transforming acidic coiled-coil containing protein 3 is a novel independent prognostic marker in non-small cell lung cancer. Jung CK; Jung JH; Park GS; Lee A; Kang CS; Lee KY Pathol Int; 2006 Sep; 56(9):503-9. PubMed ID: 16930330 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of HLA class I alleles on postoperative prognosis of lung cancer patients in Japan. Nagata Y; Hanagiri T; Mizukami M; Kuroda K; Shigematsu Y; Baba T; Ichiki Y; Yasuda M; So T; Takenoyama M; Sugio K; Nagashima A; Yasumoto K Lung Cancer; 2009 Jul; 65(1):91-7. PubMed ID: 19054590 [TBL] [Abstract][Full Text] [Related]
19. Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma. Chang H; Iizasa T; Shibuya K; Iyoda A; Suzuki M; Moriya Y; Liu TL; Hiwasa T; Hiroshima K; Fujisawa T Cancer; 2004 Apr; 100(8):1665-72. PubMed ID: 15073855 [TBL] [Abstract][Full Text] [Related]
20. L-type amino acid transporter 1 expression is a prognostic marker in patients with surgically resected stage I non-small cell lung cancer. Imai H; Kaira K; Oriuchi N; Yanagitani N; Sunaga N; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Histopathology; 2009 Jun; 54(7):804-13. PubMed ID: 19635099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]